Legal Representation
Attorney
Leesa N. Weiss
USPTO Deadlines
Next Deadline
111 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 20, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 19, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 19, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 19, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 26, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 1, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 1, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 11, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 26, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 26, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 29, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Clinical and in vitro diagnostic reagents for medical use; Clinical and in vitro diagnostic reagents for medical use, namely, immunoassay test kits, consisting primarily of in vitro reagents for the diagnosis, prognosis, and monitoring of conditions of physiological significance; Clinical and in vitro diagnostic reagents for medical diagnostic assay kits composed primarily of clinical and in vitro medical diagnostic reagents and also composed of laboratory equipment being microarrays for testing and analysis of body fluids, for medical diagnosis; Medical diagnostic assay test kits composed primarily of clinical and in vitro medical diagnostic reagents and also composed of laboratory equipment being microarrays for testing and analysis of body fluids
Class 009
Computer hardware; downloadable software and downloadable mobile applications for use in the diagnosis, prognosis, and monitoring of brain and head trauma and injury through the analysis of diagnostic reagents; downloadable software and downloadable mobile applications for assessing physiologic measures, performing behavioral, cognitive, psychological, vestibular and ocular motility based neuro-diagnostic tests, for accessing data, reports, and summaries of patient autonomic nervous system testing, and for reporting a combined multi-modality score for the diagnosis, prognosis and monitoring of brain and head trauma and injury
Class 010
Medical testing devices for measuring disease markers, in the fields of immunoassays, and molecular diagnostics, including the use of an assay test panel, composed of one or more brain-enriched biomarkers, and for measuring blood flow and imaging for the purposes of identifying, testing for, detecting, monitoring, and reporting on brain and head trauma and injury
Class 044
Medical testing and assessment services, for the testing, evaluation, analysis and reporting of patient results associated with brain and head trauma and injury from multi-modalities for diagnostic and medical testing purposes
Classification
International Classes
005
009
010
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TBI EVALUATION"